DermaRite Industries, LLC: Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (ND
Read the official notice at FDA (drug) →
Get alerts for DermaRite Industries
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- DermaRite Industries, LLC
- Product
- Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
- Reason / hazard
- CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA
- Recall initiated
- 2025-08-27
- Code info
- All lots on or before expiry date 08/2027
- Product quantity
- 8,378 containers
- Voluntary mandated
- Voluntary: Firm initiated
- City
- North Bergen
- State
- NJ
- Country
- United States
- Event id
- 97625
Free daily digest + "My products" watchlist